Skip to content

Newsletter The Edition

Funding flux

The strong start to the year for Australian startup funding may be short-lived as Donald Trump's tariffs cause turbulence across the ecosystem.

The Australian biotech sector faces increased uncertainty from Trump's pharmaceutical tariff threats. Shutterstock/Gorodenkoff.